全文获取类型
收费全文 | 267篇 |
免费 | 11篇 |
国内免费 | 10篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 13篇 |
妇产科学 | 2篇 |
基础医学 | 30篇 |
口腔科学 | 8篇 |
临床医学 | 28篇 |
内科学 | 48篇 |
皮肤病学 | 10篇 |
神经病学 | 1篇 |
特种医学 | 6篇 |
外科学 | 30篇 |
综合类 | 38篇 |
预防医学 | 25篇 |
眼科学 | 5篇 |
药学 | 27篇 |
中国医学 | 2篇 |
肿瘤学 | 14篇 |
出版年
2023年 | 3篇 |
2022年 | 2篇 |
2021年 | 8篇 |
2018年 | 4篇 |
2017年 | 4篇 |
2015年 | 9篇 |
2014年 | 20篇 |
2013年 | 14篇 |
2012年 | 12篇 |
2011年 | 6篇 |
2010年 | 7篇 |
2009年 | 15篇 |
2008年 | 4篇 |
2007年 | 11篇 |
2006年 | 18篇 |
2005年 | 6篇 |
2004年 | 9篇 |
2003年 | 10篇 |
2002年 | 6篇 |
2001年 | 11篇 |
2000年 | 6篇 |
1999年 | 11篇 |
1998年 | 10篇 |
1997年 | 12篇 |
1996年 | 13篇 |
1995年 | 4篇 |
1994年 | 7篇 |
1993年 | 6篇 |
1992年 | 3篇 |
1991年 | 2篇 |
1990年 | 2篇 |
1989年 | 3篇 |
1987年 | 3篇 |
1985年 | 1篇 |
1984年 | 2篇 |
1982年 | 1篇 |
1981年 | 1篇 |
1979年 | 1篇 |
1978年 | 1篇 |
1973年 | 1篇 |
1966年 | 1篇 |
1964年 | 1篇 |
1959年 | 6篇 |
1958年 | 1篇 |
1957年 | 1篇 |
1956年 | 2篇 |
1955年 | 1篇 |
1954年 | 1篇 |
1952年 | 1篇 |
1941年 | 1篇 |
排序方式: 共有288条查询结果,搜索用时 15 毫秒
71.
72.
J. D. CORTIS MSC BSC DIP. NURS. RGN RMN RNT A. S. RINOMHOTAMSC BSC RGN RMN PGCE. CERT IN COUNSELLING 《Journal of nursing management》1996,4(6):359-366
The subject of discrimination especially with regard to the ethnic minority workforce in the NHS was the focus of a specially commissioned Task Force funded by the Department of Health and the King's Fund in 1991 followed by the PSI Report published last year to help health authorities to address racial discrimination. The first of these reports, for example, states quite clearly that 'racial inequalities between managers and staff in the service are glaring … black and ethnic minority staff will not join or remain in a service which they do not see to be providing good and fair employment prospects'. This perhaps influenced the Secretary of State for Health, in 1993, to set up a programme of action which included a number of targets to be achieved. Goal seven, for example, specifically addresses nursing by stating that NHS authorities and trusts are to set local objectives to achieve representation of ethnic minority nurses at ward manager level within 5 years.
This programme seems to focus on the issue of equal opportunities but although it does make reference to 'racial harassment' it does not include 'racism'. Hence the purpose of this paper is to address the issues of equal opportunities and anti-racism from a theoretical and practice base. It also intends to offer alternatives for the way forward by focusing on local initiatives. 相似文献
This programme seems to focus on the issue of equal opportunities but although it does make reference to 'racial harassment' it does not include 'racism'. Hence the purpose of this paper is to address the issues of equal opportunities and anti-racism from a theoretical and practice base. It also intends to offer alternatives for the way forward by focusing on local initiatives. 相似文献
73.
REZAN TOPALOLU ALPAY ÇELIKER ÜMIT SAATÇI KAMER KLINÇ AYÇIN BAKKALOLU NESRIN BEBAS SEZAÖZEN KÜRSdedil;AT TOKEL 《Pediatrics international》1998,40(1):26-29
Thirteen carnitine-deficient children (mean age, 16.1 ±2.56 years) on a three-times-weekly hemodialysis program for at least 1 year, and 11 healthy age matched children were involved in the study. All the patients had stable blood pressure and hemoglobin (Hb) levels with a maintenance dose of erythropoetin and none were digitalized. The total carnitine (TC) and free carnitine (FC) plasma levels were sampled prior to hemodialysis (HD) before and after 3 months of carnitine supplementation. A free carnitine (FC) to acylcarnitine (AC) ratio less than 4 was defined as carnitine deficiency. Intravenous L-carnitine was injected at a dose of 20–4.0 mg/kg three times weekly at the end of each dialysis session for a 3-month period. Echocardiographic examination was performed the day following HD, before and after carnitine treatment. Systolic and diastolic functions of the left ventricle, including the ejection fraction, were measured. Almost all the parameters were significantly different in controls and hemodiaiyzed patients. In carnitine-deficient hemodiaiyzed patients. 3 months of L-carnitine supplementation resulted in a significant increase in blood carnitine levels and the FC/AC ratio, but this was not associated with any significant improvement of cardiac function. Furthermore no significant changes were observed in plasma triglycerides, total cholesterol or other lipoprotein parameters before or after carnitine supplementation. Although there was a moderate increase in mean hematocrit (Hct) and Hb levels, these also did not reach statistically significant levels. These results suggest that the 3 months of carnitine supplementation is not sufficient to ameliorate cardiac function or increase Hb levels in children. 相似文献
74.
Review article: consensus statements on therapeutic drug monitoring of anti‐tumour necrosis factor therapy in inflammatory bowel diseases 下载免费PDF全文
N. Mitrev N. Vande Casteele C. H. Seow J. M. Andrews S. J. Connor G. T. Moore M. Barclay J. Begun R. Bryant W. Chan C. Corte S. Ghaly D. A. Lemberg V. Kariyawasam P. Lewindon J. Martin R. Mountifield G. Radford‐Smith P. Slobodian M. Sparrow C. Toong D. van Langenberg M. G. Ward R. W. Leong IBD Sydney Organisation the Australian Inflammatory Bowel Diseases Consensus Working Group 《Alimentary pharmacology & therapeutics》2017,46(11-12):1037-1053
75.
76.
The prognostic significance of post-infarction angina pectoris and the effect of verapamil on the incidence of angina pectoris and prognosis 总被引:1,自引:0,他引:1
JESPERSEN C. M.; FISCHER HANSEN J.; SPANGE MORTENSEN L.; THE DANISH STUDY GROUP ON VERAPAMIL IN MYOCARDIAL INFARCTION 《European heart journal》1994,15(2):270-276
The prognostic sign of angina pectoris and the effect of interventionwith verapamil on the incidence of angina pectoris were studiedin patients recovering from myocardial infarction and includedin the Danish Verapamil Infarction Trial II. During the secondweek after admission patients were double-blindly randomizedto treatment with verapamil 360 mg. day1 or placebo.Treatment was continued for up to 18 months. At discharge anginapectoris was reported in 11% of 869 patients randomized to verapamiland in 12% of 888 randomized to placebo (ns). One month afterdischarge a significantly increase in the prevalance of anginapectoris was reported in both the verapamil (33%) (P<0·001)and the placebo groups (39%) (P <0·001). The one monthprevalence of angina pectoris (P=0·03) and the 18 monthsoverall incidence of angina pectoris (P= 0·002) wereboth .sigificant lower in the verapamil group compared withplacebo. Stable angina pectoris during the first month of follow-upwas a significant predictor of major events (i.e. death or reinfarction)(hazard ratio = 1·45; 95% confidence limits: 1·101·89). As verapamil significantly reduced the incidenceof angina pectoris during daily activities, and thereby thenumber of patients at high risk, the beneficial effect of verapamilin reducing major events in patients recovering from myocardialinfarction is likely to be due to abolishing myocardial ischaemia. 相似文献
77.
Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults 总被引:6,自引:0,他引:6
SEUNG H PARK WOO K JEON SANG H KIM HONG J KIM DONG I PARK YONG K CHO IN K SUNG CHONG I SOHN DONG K KEUM BYUNG I KIM 《Journal of gastroenterology and hepatology》2006,21(1):138-143
Background and Aim: Differences in the prevalence of non‐alcoholic fatty liver disease (NAFLD) between Eastern and Western populations are primarily attributable to differences in definitions and biased population selection. Thus, the aim of the present study was to accurately determine the actual prevalence of NAFLD by sonography and to characterize the risk factors for NAFLD. Methods: The present cross‐sectional study was performed with data obtained from 6648 subjects, all of whom were older than 20 years of age (3530 men and 3118 women). The term ‘non‐drinker’ was applied to men who consumed less than 30 g alcohol/day and to women who consumed less than 20 g alcohol/day. Non‐alcoholic fatty liver disease was defined as a sonographically detected fatty liver in the absence of viral hepatitis in a non‐drinker. Results: Of the 1613 subjects who were diagnosed with sonographic fatty liver, 1240 were non‐drinkers and had no viral hepatitis. Overall, the unadjusted and age‐adjusted prevalences of NAFLD were 18.7% (23% in men, 13.7% in women) and 16.1% (21.6% in men, 11.2% in women), respectively. Multivariate analysis revealed that several risk factors were profoundly associated with the prevalence of NAFLD, including obesity, insulin resistance, hyperlipidemia and hyperglycemia in both genders, as well as age, menopausal status and estrogen medication in women only. Conclusions: These results demonstrate that the prevalence of NAFLD in Korean adults, according to sonographic surveys, is comparable to that seen in more developed countries. From the perspective of increasing obesity, the high prevalence rates noted in the study may herald an increased burden of chronic liver disease in the Korean population. 相似文献
78.
目的研究慢性重型乙型肝炎Th1/Th2类细胞因子的水平及其对预后的影响。方法采集112例慢性重型乙型肝炎患者外周血,以30例慢性乙型肝炎(CHB)患者和30名健康体检者作为对照,应用ELISA法检测IL-4和IFN-γ水平,荧光PCR法检测HBVDNA载量,分析重型肝炎患者不同分期细胞因子水平以及与HBVDNA载量及短期预后的关系。结果慢性重型乙型肝炎患者外周血IL-4、IFN-γ水平和Th1/Th2比值明显高于CHB患者和健康体检者(z值分别为8.968,10.004和26.067,P值分别为0.009,0.007和0.000);晚期重型肝炎患者的IL-4水平明显高于早、中期患者(z值分别为3.672和3.158,P值分别为0.000和0.002),但Th1/Th2比值低于早、中期患者(Z值分别为3.161和2.166,P值分别为0.002和0.030);不同HBVDNA复制水平的重型肝炎患者IL4、IFN-γ及Th1/Th2比值差异无统计学意义(z值分别为4.431,2.626和0.140,P值分别为0.219,0.403和0.987);但患者外周血IL4浓度越高,12周的病死率越高。结论Th1/Th2失衡导致重型肝炎的发生,随着病情加重,Th1/Th2比值下降,提示短期预后不良。 相似文献
79.
MARKÊNIA KÉLIA SANTOS ALVES VALESKA PORTELA LIMA ADRIANA CAMARGO FERRASI MARIA APARECIDA RODRIGUES MARIA INÊS DE MOURA CAMPOS PARDINI SILVIA HELENA BAREM RABENHORST 《APMIS : acta pathologica, microbiologica, et immunologica Scandinavica》2010,118(4):297-307
Alves MKS, Lima VP, Ferrasi AC, Rodrigues MA, de Moura Campos Pardini MI, Rabenhorst SHB. CDKN2A promoter methylation is related to the tumor location and histological subtype and associated with Helicobacter pylori flaA(+) strains in gastric adenocarcinomas. APMIS 2010; 118: 297–307. Promoter hypermethylation of CDKN2A (p16INK4A protein) is the main mechanism of gene inactivation. However, its association with Helicobacter pylori infection is a controversial issue. Therefore, we examined a series of gastric adenocarcinomas to assess the association between p16INK4A inactivation and H. pylori genotype (vacA, cagA, cagE, virB11 and flaA) according to the location and histological subtype of the tumors. p16INK4A expression and CDKN2A promoter methylation were found in 77 gastric adenocarcinoma samples by immunohistochemistry and methylation‐specific PCR, respectively. Helicobacter pylori infection and genotype were determined by PCR. A strong negative correlation between immunostaining and CDKN2A promoter region methylation was found. In diffuse subtype tumors, the inactivation of p16INK4A by promoter methylation was unique in noncardia tumors (p = 0.022). In addition, H. pylori‐bearing flaA was associated with non‐methylation tumors (p = 0.008) and H. pylori strain bearing cagA or vacAs1m1 genes but without flaA was associated with methylated tumors (p = 0.022 and 0.003, respectively). Inactivation of p16INK4A in intestinal and diffuse subtypes showed distinct carcinogenic pathways, depending on the tumor location. Moreover, the process of methylation of the CDKN2A promoter seems to depend on the H. pylori genotype. The present data suggest that there is a differential influence and relevance of H. pylori genotype in gastric cancer development. 相似文献
80.
目的 观察超声引导下微波凝固治疗肝癌前后患者免疫指标的动态变化。方法 分别于微波治疗前1周及治疗后1、2、3、4周采集患者外周静脉血,用Cr51释放法检测自然杀伤细胞活性,放射免疫法测定白细胞介素-2水平,酶联免疫法测定可溶性白介素2受体水平。结果 肝癌患者存在严重免疫功能低下,与正常人比NK细胞活性与IL-2水平下降;SIL-2R水平上升,均有统计学意义(P<0.01)。微波凝固治疗肝癌后,NK细胞活性明显上升(P<0.05),SIL-2R水平明显降低(P<0.01)。结论 微波热疗后机体免疫功能增强,提高了抗肿瘤能力。 相似文献